How Drug Companies Seek To Exploit Rare DNA Mutations

Steven Pete can put his hand on a hot stove or step on a piece of glass and not feel a thing, all because of a quirk in his genes. Only a few dozen people in the world share Pete’s congenital insensitivity to pain. Drug companies see riches in his rare mutation. They also have their eye on people like Timothy Dreyer, 25, who has bones so dense he could walk away from accidents that would leave others with broken limbs. About 100 people have sclerosteosis, Dreyer’s condition.

Source: These Superhumans Are Real and Their DNA Could Be Worth Billions

I don’t have a problem with the pharmaceutical companies trying to maximize profits. Profits are necessary to help the market determine how to allocate resources. When a company makes “obscene” profits that is a signal to everyone else that resources should be taken from those enterprises incurring loses and invested in the more profitable ventures.

One the people whose mutation is highlighted in the article reminds me of a character from the book “The Girl Who Played with Fire“, the second part of the Millenium series by Stieg Larsson.  I haven’t seen the American version of the movie for the first book, but enjoyed the books & Swedish movies.